Starting TRT at a low dose: what the evidence actually says

What did @cbronsonmd actually say?

The core claim here is reassuring: starting dose on TRT doesn't matter much, as long as labs, body composition, and symptoms get checked every three months and the dose gets adjusted over time. He also puts a hard ceiling on starting doses, saying "definitely nothing over 200 to start, and definitely nothing over 300 at all period." That ceiling claim is worth examining closely.

To his credit, the emphasis on regular monitoring is clinically sound. The argument is that personalization over time matters more than where you begin. He specifically calls out 25 mg/week as "super low" but frames it as acceptable if the adjustment process is in place. The monitoring-first framing is the strongest part of this video.

Does the science back this up?

Mostly, yes, with important caveats. The idea that titration matters more than initial dose has real support. The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend starting testosterone cypionate or enanthate at 75-100 mg/week or equivalent, with adjustment based on serum levels and symptom response. Nothing in those guidelines says your starting dose locks in your outcome.

What the research does suggest, though, is that starting dose is not entirely irrelevant. A study by Snyder et al. (2016, NEJM, the Testosterone Trials) found that dose-dependent effects on bone density, anemia, and sexual function varied meaningfully at different testosterone levels. Getting to therapeutic range faster versus slower can affect early symptom resolution. So "irrelevant" is too strong a word.

• Bhasin et al., 2018, JCEM: supports individualized titration with monitoring every 3-6 months
• Snyder et al., 2016, NEJM: dose-dependent outcomes suggest starting level is not fully neutral

What did they get wrong (or right)?

The 300 mg/week hard ceiling deserves scrutiny. That number sits above standard physiologic replacement ranges. Bhasin et al. (2018) define TRT targets as mid-normal range, roughly 400-700 ng/dL, which most patients reach at doses well below 200 mg/week of testosterone cypionate. Calling 300 mg/week a permanent ceiling rather than a red flag is doing a lot of work here, and it may normalize doses that cross into supraphysiologic territory for many men.

What he got right: the three-month monitoring cadence is consistent with guidelines. Tracking body composition alongside labs, not just serum testosterone, reflects more current thinking about what TRT outcomes actually mean for patients. The point that symptoms matter as much as numbers is well-supported by Khera et al. (2016, Sexual Medicine Reviews), who found symptom-based titration outperformed number-chasing in patient satisfaction.

What he got wrong: calling starting dose "irrelevant" overstates the case. Early dose selection shapes how quickly you reach therapeutic levels, which affects time-to-symptom relief and early side effect exposure.

What should you actually know?

If you are evaluating TRT, starting dose is one variable in a larger clinical picture, not the whole story, but not meaningless either. Standard starting doses recommended in peer-reviewed guidelines cluster around 75-100 mg/week of injectable testosterone for a reason: they target physiologic replacement, not supraphysiologic levels.

Any dose above 200 mg/week starts to raise questions about intent. At that level, you are often pushing testosterone concentrations well above the normal male range, which increases cardiovascular strain, hematocrit elevation, and estradiol conversion risks (Traish et al., 2015, Journal of Andrology). A 300 mg ceiling framed as acceptable for TRT is not standard clinical practice.

• Get baseline labs before starting: total testosterone, free testosterone, hematocrit, PSA, estradiol, metabolic panel
• Recheck at 3 months, then every 6 months once stable, per Endocrine Society guidance
• Symptom tracking tools like the AMS (Aging Males Symptoms) scale add clinical value beyond lab numbers alone
• If a provider is starting you above 200 mg/week as a first dose, ask why explicitly